AU Patent

AU2002349882A1 — Q4n2neg2 enhances cftr activity

Assigned to Case Western Reserve University · Expires 2003-04-01 · 23y expired

What this patent protects

Patent listed against Kalydeco.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002349882A1
Jurisdiction
AU
Classification
—
Expires
2003-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Case Western Reserve University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.